Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.COTI-2 for cancer treatment secures US patent
The compound has been discovered by the company’s Artificial Intelligence drug discovery process, CHEMSAS. The specific cellular targeting, low toxicity, and efficacy of the drug candidate help in
The compound has been discovered by the company’s Artificial Intelligence drug discovery process, CHEMSAS. The specific cellular targeting, low toxicity, and efficacy of the drug candidate help in
Injectafer is a non-dextran intravenous iron (i.v.) replacement therapy containing ferric carboxymaltose as its active pharmaceutical ingredient. The NDA includes the data from two randomized controlled clinical trials
Two Phase 3 clinical Echo and Thrive trials evaluated the efficacy and safety of rilpivirine in 1,368 antiretroviral treatment-naïve HIV-1-infected adults. The 96 week trial demonstrated that rilpivirine
American CryoStem’s laboratory provides tissue processing and storage services which comply with the PHS Act, current FDA regulations and guidance including current Good Manufacturing Practice (cGMP) and current
Medihoney is a line of wound and burn dressings containing 80% Active Leptospermum Honey and 20% natural gelling agents. The product has been proven to help initiate healing
Serada is an extended-release, orally administered formulation of gabapentin for the treatment of menopausal hot flashes which uses the company’s Acuform drug delivery technology. Breeze 3, a randomized,
Isentress is an integrase inhibitor by Merck for the treatment of HIV-1 infection in treatment-naive and treatment-experienced adult patients as part of combination therapy. The double-blind, randomized, active-controlled,
The application enables discovery of new pharmaceutical drugs to combine image data from multiple trials in a single database, eweek.com reported. Enterprise Core-Lab-in-a-Box helps in management of medical
The company will use the fund for preclinical and clinical development of its new class of bridged bicyclic antibiotics known as Bicyclolides which are said to act as
PA32540 is an investigational coordinated-delivery tablet of immediate-release omeprazole, a proton pump inhibitor (PPI), layered around pH-sensitive aspirin. During the trial, subjects with known cardiovascular disease and already